Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 12 No. 2 (2006)

Vol. 12 No. 2 (2006)

Published: 2006-01-01

Editorial

  • Editorial: Much ado about nothing

    Simon Bright, Nigel Poole
    • PDF

Article

  • Downstream and into deep biology: Evolving business models in 'top tier' genomics companies

    Harry Rothman, Alison Kraft
    • PDF
  • The new tax rules for university spin-outs: An answer to all the problems?

    Alison Hughes, Joanne Brien
    • PDF
  • The convergence of biotechnology and nanotechnology: Why here, why now?

    Tom C Thomas, Rachelle Acuña-Narvaez
    • PDF
  • The development of the South African biotech sector

    Britt Akermann, Faiz Kermani
    • PDF
  • Stem cell patenting

    Claire Baldock
    • PDF
  • The dismantling of redundant dichotomies: Biotechnology as an exemplar of university–industry collaboration

    Michael J Lynskey
    • PDF
  • Growth drivers and resistors of the influenza market: The importance of cell culture flu

    Mark Belsey, David Evans, Alex Pavlou, John Savopoulos
    • PDF

Legal and Regulatory Updates

  • Legal and regulatory update

    John Wilkinson
    • PDF
  • Obituary

    JCB Editor
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust